Upload File

The top documents tagged [investigators brochure]

ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2 Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research
ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2 Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research
216 views
Tool: Training Presentation: Clinical Research Responsibilities for NIDCR-Funded Investigators Purpose: To provide an overview of the key roles and responsibilities
Tool: Training Presentation: Clinical Research Responsibilities for NIDCR-Funded Investigators Purpose: To provide an overview of the key roles and responsibilities
215 views
Regulatory Submission Process Clinical Study Application: 1. Submit an appointment requestappointment request 2. Fill one of the three templates: - BE
Regulatory Submission Process Clinical Study Application: 1. Submit an appointment requestappointment request 2. Fill one of the three templates: - BE
214 views
© Teva Pharmaceuticals Europe 02 October 2007 Pharmacovigilance and electronic reporting Background and procedures Wendy Huisman EU QP Teva Pharmaceuticals
© Teva Pharmaceuticals Europe 02 October 2007 Pharmacovigilance and electronic reporting Background and procedures Wendy Huisman EU QP Teva Pharmaceuticals
220 views
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004
218 views
Bashi Ratterree, RN, BSN, CCRP Nurse Coordinator, CHM OHSU Knight Cancer Institute Mail code: UHN73C 503-494-9982 ratterre@ohsu.edu ratterre@ohsu.edu
Bashi Ratterree, RN, BSN, CCRP Nurse Coordinator, CHM OHSU Knight Cancer Institute Mail code: UHN73C 503-494-9982 [email protected] [email protected]
222 views
Monitoring and Special Considerations for Multi-Center Trials September 10, 2010 Pav Aujla, MS, CCRP, RAC Primo N. Lara, Jr. MD A Translational Innovation
Monitoring and Special Considerations for Multi-Center Trials September 10, 2010 Pav Aujla, MS, CCRP, RAC Primo N. Lara, Jr. MD A Translational Innovation
212 views
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
216 views
The Good, The Bad and The Ugly of Clinical Research Sites
The Good, The Bad and The Ugly of Clinical Research Sites
214 views
Responsible Conduct of Research Fall-1, 2013 Delia Y. Wolf, MD, JD, MSCI Assistant Dean, Regulatory Affairs and Research Compliance Harvard School of Public
Responsible Conduct of Research Fall-1, 2013 Delia Y. Wolf, MD, JD, MSCI Assistant Dean, Regulatory Affairs and Research Compliance Harvard School of Public
218 views
EMORY INSTITUTIONAL REVIEW BOARD VERSION 8-1-13 Unanticipated Problems, Protocol Deviations and Non-Compliance
EMORY INSTITUTIONAL REVIEW BOARD VERSION 8-1-13 Unanticipated Problems, Protocol Deviations and Non-Compliance
216 views
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager
216 views